HireRight (HRT) IPO Opens 5% Lower, Valuing Co. at ~$1.4 Billion

Today's IPO for HireRight (NYSE: HRT) opened for trading at $18 after pricing 22,222,222 shares of its common stock at $19.00 per share, below the expected $21-$24 range.

The valuation based on the opening price is $1.43 billion.

Credit Suisse and Goldman Sachs & Co. LLC are acting as lead bookrunners for the offering. Barclays, Jefferies, RBC Capital Markets, William Blair, Baird, KeyBanc Capital Markets, Stifel and Truist Securities will act as bookrunners for the offering. Citizens Capital Markets, SPC Capital Markets LLC, Penserra Securities LLC, R. Seelaus & Co., LLC and Roberts & Ryan will act as co-managers for the offering.

HireRight provides comprehensive background screening, verification, identification, monitoring, and drug and health screening services for more than 40,000 customers across the globe.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• China chipmaker YMTC files for $4.9 billion IPO
• William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business